Equity Method Investments - BioCision, LLC (Details) - USD ($) $ in Thousands		2 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Nov. 28, 2016	Nov. 28, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2016
Schedule of Equity Method Investments [Line Items]
Equity method investments			$ 32,628		$ 32,628		$ 27,273
Equity in earnings of equity method investments			2,530	$ 379	7,249	$ 1,248
Non-cash consideration transferred					10,348
Gain on settlement of equity method investment					1,847
BioCision, LLC
Schedule of Equity Method Investments [Line Items]
Joint venture interest, percentage							20.00%
Equity method investments	$ 1,200	$ 1,200					$ 1,700
Equity in earnings of equity method investments		$ (500)		$ (300)		(700)
Recognized measurement gains						$ 500
Annual interest rate (percent)							10.00%
Equity interest in acquiree, percentage (as a percent)	20.00%	20.00%
Equity in earnings of equity method investments, adjustment		$ 200
BioCision, LLC | Maximum
Schedule of Equity Method Investments [Line Items]
Stock warrant							$ 100
Convertible Debt Securities
Schedule of Equity Method Investments [Line Items]
Convertible debt securities, carrying value	$ 5,800	5,800
Convertible Debt Securities | BioCision, LLC
Schedule of Equity Method Investments [Line Items]
Investment maturity period							5 years
Convertible debt securities							$ 5,800
Other Assets
Schedule of Equity Method Investments [Line Items]
Loan receivable, carrying value	$ 1,600	$ 1,600					1,500
Other Assets | BioCision, LLC
Schedule of Equity Method Investments [Line Items]
Loan receivable, carrying value							1,500
Loan receivable							1,500
Other Income
Schedule of Equity Method Investments [Line Items]
Loss on settlement of financial instruments					200
Other Income | BioCision, LLC
Schedule of Equity Method Investments [Line Items]
Gain on settlement of equity method investment					1,800
Cool Lab, LLC
Schedule of Equity Method Investments [Line Items]
Percentage of voting interests acquired (as a percent)	100.00%	100.00%
Total purchase price	$ 15,200
Payments to acquire businesses	4,800
Liabilities incurred	100
Non-cash consideration transferred	10,300
Equity method investments, fair value disclosure	3,100
Convertible debt securities and warrants	5,600
Term notes, fair value disclosure	1,600
Loan receivable, carrying value	1,600	$ 1,600
Cool Lab, LLC | BioCision, LLC
Schedule of Equity Method Investments [Line Items]
Net carrying value of assets transferred	900
Cool Lab, LLC | Convertible Debt Securities
Schedule of Equity Method Investments [Line Items]
Convertible debt securities	5,600	5,600
Convertible debt securities, carrying value	5,800	5,800
Significant Unobservable Inputs (Level 3) | Cool Lab, LLC
Schedule of Equity Method Investments [Line Items]
Loan receivable, fair value	1,600	1,600
Warrants
Schedule of Equity Method Investments [Line Items]
Stock warrant			$ 0		0
Loss on settlement of financial instruments					$ 37
Warrants | Maximum
Schedule of Equity Method Investments [Line Items]
Stock warrant							$ 100
Warrants | Cool Lab, LLC | Maximum
Schedule of Equity Method Investments [Line Items]
Stock warrant	100	100
Warrants | Significant Unobservable Inputs (Level 3) | Cool Lab, LLC | Maximum
Schedule of Equity Method Investments [Line Items]
Stock warrant	$ 100	$ 100